Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2006-08-18

Clinical Trial Update: Dehydroepiandrosterone Effects on HIV-1 Replication [Phase 2]

View source ↗

Summary

A completed Phase 2 trial examining whether dehydroepiandrosterone (DHEA) affects HIV-1 replication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dehydroepiandrosterone (DHEA) (dehydroepiandrosterone)

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: HIV Infections | Phase 2 | Status: COMPLETED